Post-authorisation safety study (PASS) to evaluate risk minimisation measures for medication errors with Uptravi during the titration phase in patients with pulmonary arterial hypertension (PAH) in clinical practice (EDUCATE)

15/10/2018
18/08/2026
EU PAS number:
EUPAS25699
Study
Ongoing

ENCePP Code of conduct

No
Data sources

Data sources (types)

Other

Data sources (types), other

Survey
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No
Procedures
No information provided.